Pediatric RSV Vaccine - Wake Research

Pediatric RSV Vaccine

Mother smiles while holding happy baby getting heartbeat checked.

Precious lungs need protection from Serious Respiratory Illness

Mount Vernon Clinical Research is looking for children 5 to 23 months old who are in generally good health to take part in a clinical research trial. The purpose of this trial is to evaluate the safety of and immune system’s response to 2 investigational vaccines. These investigational vaccines, called mRNA-1345 and mRNA-1365, are being evaluated to see if they can protect against respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in children ages 5 to 23 months.

To qualify, you must:

  • Have a child age 5 to 23 months in generally good health

Qualified participants will receive:

  • Compensation for time and travel
See If You Qualify

WHAT TO EXPECT

THREE EASY STEPS

pictured: two hands manipulate a smart phone surrounded by floating illustrated icons of opening an email and making a phone call | Wake Clinical Research

STEP 1

Fill out your contact information or give us a call

pictured: two hands holding a pen and paper; in the background is a doctor wearing a lab coat and stethoscope | Wake Clinical Research

STEP 2

A recruiter will reach out shortly and ask you some questions

pictured: a doctor smiles and greets a study participant | Wake Clinical Research

STEP 3

If you’re qualified, you will be scheduled for an office visit

Mount Vernon Clinical Research

Study Hotline
+1-404-692-4313

Main Office
+1-404-843-4400

Our Hours
Mon-Fri: 8AM to 5PM

Location
755 Mount Vernon Hwy NE Unit 200
Sandy Springs, GA 30328